Stockreport

Immix Biopharma to Participate in Upcoming Investor Conferences

Immix Biopharma, Inc.  (IMMX) 
PDF LOS ANGELES, CA, March 03, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL [Read more]